Hepcinat LP
In stock
Description
Hepcinat LP is an antiviral prescription medication manufactured by Natco Pharma for the treatment of chronic Hepatitis C Virus (HCV) infection in adults.
The combination of Ledipasvir and Sofosbuvir disrupts the replication process of the Hepatitis C virus. Ledipasvir targets the viral NS5A protein, while Sofosbuvir inhibits the NS5B RNA polymerase enzyme. Together, they significantly lower the viral load in the blood and prevent the virus from multiplying, which can help clear the infection and prevent liver damage.
Specifications
| Strength | 90 + 400 Mg |
|---|---|
| Main Ingredients | Ledipasvir 90 mg and Sofosbuvir 400 mg |
| Form | Oral film-coated tablets |
| Pack szie | 28 Tablets |
| Treatment | Chronic Hepatitis c |
